关注
Roghayyeh Baghban
Roghayyeh Baghban
Shiraz University of Medical Sciences, Shiraz, Iran.
在 tbzmed.ac.ir 的电子邮件经过验证
标题
引用次数
引用次数
年份
Tumor microenvironment complexity and therapeutic implications at a glance
R Baghban, L Roshangar, R Jahanban-Esfahlan, K Seidi, ...
Cell Communication and Signaling 18, 1-19, 2020
12892020
Yeast expression systems: overview and recent advances
R Baghban, S Farajnia, M Rajabibazl, Y Ghasemi, AA Mafi, R Hoseinpoor, ...
Molecular biotechnology 61, 365-384, 2019
2142019
New developments in Pichia pastoris expression system, review and update
R Baghban, S Farajnia, Y Ghasemi, M Mortazavi, N Zarghami, N Samadi
Current pharmaceutical biotechnology 19 (6), 451-467, 2018
502018
Camelid‐derived heavy‐chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris
R Baghban, SLM Gargari, M Rajabibazl, S Nazarian, H Bakherad
Biotechnology and applied biochemistry 63 (2), 200-205, 2016
432016
Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update
M Afarid, S Mahmoodi, R Baghban
Journal of Nanobiotechnology 20 (1), 361, 2022
322022
Combination therapy with KRAS siRNA and EGFR inhibitor AZD8931 suppresses lung cancer cell growth in vitro
H Zarredar, S Pashapour, K Ansarin, M Khalili, R Baghban, S Farajnia
Journal of cellular physiology 234 (2), 1560-1566, 2019
292019
Chitosan-based biomaterials for the treatment of bone disorders
M Rahimi, SM Mir, R Baghban, G Charmi, CM Plummer, ...
International Journal of Biological Macromolecules 215, 346-367, 2022
252022
Were magnetic materials useful in cancer therapy?
R Baghban, M Afarid, J Soleymani, M Rahimi
Biomedicine & Pharmacotherapy 144, 112321, 2021
242021
Development and characterization of a novel conductive polyaniline-g-polystyrene/Fe3O4 nanocomposite for the treatment of cancer
AA L Ahmadkhani, E Mostafavi, S Ghasemali, R Baghban, H Pazoki-Toroudi, S ...
Artificial cells, nanomedicine, and biotechnology 47 (1), 873-881, 2019
202019
Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19)
R Baghban, A Ghasemian, S Mahmoodi
Archives of Microbiology 205 (4), 150, 2023
152023
New developments in anti-angiogenic therapy of cancer, review and update
S Ghasemali, S Farajnia, A Barzegar, M Rahmati-Yamchi, R Baghban, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2021
152021
Association of rs780094 polymorphism of glucokinase regulatory protein with non-alcoholic fatty liver disease
S Mohammadi, S Farajnia, M Shadmand, F Mohseni, R Baghban
BMC Research Notes 13, 1-5, 2020
152020
Current trends in targeted therapy for drug-resistant infections
L Rahbarnia, S Farajnia, B Naghili, V Ahmadzadeh, K Veisi, R Baghban, ...
Applied microbiology and biotechnology 103, 8301-8314, 2019
142019
Design and in silico evaluation of a novel cyclic disulfide-rich anti-VEGF peptide as a potential antiangiogenic drug
R Baghban, S Ghasemali, S Farajnia, R Hoseinpoor, S Andarzi, ...
International Journal of Peptide Research and Therapeutics 27, 2245-2256, 2021
122021
CRISPR‐Cas system: Toward a more efficient technology for genome editing and beyond
V Ahmadzadeh, S Farajnia, R Baghban, L Rahbarnia, H Zarredar
Journal of Cellular Biochemistry 120 (10), 16379-16392, 2019
112019
Engineering of ocriplasmin variants by bioinformatics methods for the reduction of proteolytic and autolytic activities
R Baghban, S Farajnia, Y Ghasemi, M Mortazavi, S Ghasemali, ...
Iranian Journal of Medical Sciences 46 (6), 454, 2021
52021
Mutational Analysis of Ocriplasmin to Reduce Proteolytic and Autolytic Activity in Pichia pastoris
R Baghban, S Farajnia, Y Ghasemi, R Hoseinpoor, A Safary, M Mortazavi, ...
Biological Procedures Online 22, 1-12, 2020
52020
Recent advancements in nanomaterial-laden contact lenses for diagnosis and treatment of glaucoma, review and update
R Baghban, MR Talebnejad, A Meshksar, M Heydari, MR Khalili
Journal of Nanobiotechnology 21 (1), 402, 2023
32023
WITHDRAWN: nucleic acid-based vaccines platform against Covid-19 pandemic
R Baghban, S Mahmoodi
Current molecular medicine, 2022
12022
Assessment of E. coli Expression System for Overexpression of Active Recombinant Ocriplasmin
R Baghban, S Farajnia, Y Ghasemi, M Mortazavi, N Samadi, N Zarghami
Advanced Pharmaceutical Bulletin 11 (3), 564, 2021
12021
系统目前无法执行此操作,请稍后再试。
文章 1–20